Alloy Therapeutics describes itself as a biotechnology ecosystem company that enables pre-competitive drug discovery at all levels. Alloy currently offers licensing in antibody and TCR platforms, drug discovery and optimization services, and subscription-based access to pre-competitive technology.
Alloy utilizes highly immunocompetent transgenic mice to produce maximum diversity and epitopic coverage with their ATX-Gx antibody platform. They also offer their ATX-CLC platform for common-light chain bispecific and multispecific discovery as well as their ATX-SiD platform for the discovery of single-domain antibodies. The Keyway TCR Discovery Services offer access to custom therapeutic TCR mimics and engineered TCRs against custom targets.
Claim company profile to post jobs directly on this page and this website.